Meridian Bioscience (NASDAQ:VIVO) reported quarterly earnings of $0.16 per share which met the analyst consensus estimate. This is a 27.27 percent decrease over earnings of $0.22 per share from the same period last year. The company reported quarterly sales of $67.80 million which beat the analyst consensus estimate of $66.82 million by 1.47 percent. This is a 6.75 percent increase over sales of $63.51 million the same period last year.
Elon Musk Reacts to ChatGPT’s ‘Controversial’ Labeling of Him, Other Public Figures
Tesla and Twitter CEO Elon Musk reacted to a social media post on Sunday that indicated that he, Donald Trump, and many other leaders and celebrities were
